| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.6M | -43.9% | -33.0% |
| Cost of Revenue | $2.5M | +17.5% | -42.9% |
| R&D Expense | $13.9M | +0.7% | +20.5% |
| SG&A Expense | $11.2M | -8.9% | -17.3% |
| Operating Income | -$18.9M | -47.3% | -14.4% |
| Pre-tax Income | -$19.6M | -47.8% | +5.0% |
| Income Tax | $8K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.4M | -5.3% | -32.3% |
| Short-term Investments | $33.4M | -15.7% | -36.8% |
| Inventory | $1.9M | -0.5% | -7.9% |
| Current Assets | $76.2M | -14.1% | -32.5% |
| Total Assets | $124.0M | -10.3% | -16.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$39.5M | — | — |
| Capital Expenditures | $4.0M | — | — |
| Investing Cash Flow | $17.8M | — | — |
| Financing Cash Flow | $27.7M | — | — |
| Free Cash Flow | -$43.4M | — | — |
| -20.0% |
| -20.0% |
| Net Income | -$19.6M | -47.8% | +5.0% |
| EPS (Basic) | -$0.22 | -37.5% | +24.1% |
| EPS (Diluted) | -$0.22 | -37.5% | +24.1% |
| $18.5M |
| +21.3% |
| -47.4% |
| Long-term Debt | $39.7M | +0.9% | +38.8% |
| Total Liabilities | $85.4M | +3.4% | +14.2% |
| Stockholders' Equity | $38.5M | -30.7% | -47.5% |